Technical Analysis for HOOK - HOOKIPA Pharma Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Inside Day | Range Contraction | -1.17% | |
Earnings Movers | Other | -0.97% | |
Inside Day | Range Contraction | -0.97% | |
50 DMA Support | Bullish | 1.34% | |
Earnings Movers | Other | 1.34% | |
Gapped Up | Strength | 1.34% | |
20 DMA Resistance | Bearish | 0.13% | |
Gapped Up | Strength | 0.13% | |
NR7 | Range Contraction | -1.67% | |
NR7-2 | Range Contraction | -1.67% |
Alert | Time |
---|---|
10 DMA Support | about 9 hours ago |
Rose Above Previous Day's High | about 9 hours ago |
1.5x Volume Pace | about 9 hours ago |
Up 2% | about 9 hours ago |
Down 1% | about 10 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 03/25/2024
HOOKIPA Pharma Inc. Description
HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Hepatitis B Transplantation Immunodeficiency Hepatitis B Virus Viral Disease Papillomavirus Gilead Sciences Immunotherapeutics Kidney Transplant
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.05 |
52 Week Low | 0.41 |
Average Volume | 524,126 |
200-Day Moving Average | 0.68 |
50-Day Moving Average | 0.70 |
20-Day Moving Average | 0.74 |
10-Day Moving Average | 0.72 |
Average True Range | 0.05 |
RSI (14) | 48.45 |
ADX | 11.69 |
+DI | 16.88 |
-DI | 14.37 |
Chandelier Exit (Long, 3 ATRs) | 0.71 |
Chandelier Exit (Short, 3 ATRs) | 0.80 |
Upper Bollinger Bands | 0.81 |
Lower Bollinger Band | 0.67 |
Percent B (%b) | 0.29 |
BandWidth | 18.54 |
MACD Line | 0.00 |
MACD Signal Line | 0.01 |
MACD Histogram | -0.0051 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.76 | ||||
Resistance 3 (R3) | 0.76 | 0.75 | 0.75 | ||
Resistance 2 (R2) | 0.75 | 0.74 | 0.75 | 0.75 | |
Resistance 1 (R1) | 0.73 | 0.73 | 0.73 | 0.73 | 0.74 |
Pivot Point | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 |
Support 1 (S1) | 0.70 | 0.71 | 0.70 | 0.70 | 0.68 |
Support 2 (S2) | 0.69 | 0.70 | 0.69 | 0.68 | |
Support 3 (S3) | 0.67 | 0.69 | 0.67 | ||
Support 4 (S4) | 0.67 |